Does error localization data qualify? A fit scorecard for laboratory correction histories

Short answer

Rate eight things as strong, borderline or weak: headcount, operating history, rights including client contracts, whether corrected reports keep the original and a reason, whether one ID links the value across every system it passes through, how long interface logs survive, whether mapping changes are dated, and who can authorize a discussion. A laboratory fits well when it can show the value at each hop, so the first wrong step can be found. Ask the laboratory director, quality manager or IT lead; never request records.

Visual briefFull-size diagram
A horizontal gauge from 0 to 8 strong answers with weak, borderline and strong zones; eight criteria tiles for a fictional 450-person clinical reference laboratory turn green or orange, and the pointer settles at 6 strong answers, in the strong zone.
Illustrative rating for a fictional laboratory. The scorecard organizes an introduction; it does not predict acceptance or a payout.

This scorecard belongs to error localization, which traces one corrected glucose result through four systems. Here the task is deciding whether a specific laboratory is worth introducing for this kind of record, and how confident to be.

How the rating works

Count strong answers out of eight. Borderline answers do not count toward the total but are written down, because they become the open items in the introduction. Three criteria are gates: if size, rights or the authorized contact is weak, stop and resolve it first.

Strong answersZoneWhat it means
6 to 8StrongCorrection histories likely show each hop; introduce and list the borderline items
3 to 5BorderlineQuality records exist, but one hop may be invisible; introduce only with the gaps named
0 to 2WeakThe lab has quality data, not localized errors; wait

The criteria lean on what regulation already fixes. Under 42 CFR 493.1291, a U.S. laboratory that finds an error in a reported result must issue a corrected report and keep duplicates of both the original and the corrected report. Under 42 CFR 493.1105, it must be able to retrieve original, preliminary and corrected reports for at least 2 years after reporting, and pathology reports for at least 10. So the report side is often strong by default. The interface side is not regulated in the same way, which is why it gets its own row.

Eight criteria, applied to a correction history

The generic screen is in the company qualification checklist. This version applies it to laboratory corrections.

CriterionStrongBorderlineWeakWho answers
Company size (gate)Well over 50 full-time employees at peakNear 50Under 50 full-time, or mostly contractorsCEO or HR
Operating historySeveral years in one lab information systemYears split by a system replacementRecently openedLaboratory director
Rights (gate)Lab owns its records; client and vendor terms knownSome client or interface vendor contracts unreviewedA hospital client or parent controls the recordsCEO or counsel
Original and reason keptEach corrected report keeps the original, a status and a reasonOriginal kept; reason in free textOriginal overwrittenQuality manager
Hop linkageOne accession or result ID across analyzer, lab system, interface and receiving recordID shared by some hopsNo common keyIT lead
Interface log retentionOutbound message content kept a year or moreKept for weeks, or receipts onlyNot keptIntegration team
Mapping change controlUnit, range and template changes dated and tied to a ticketChanges dated, no ticketUndocumentedIT lead
Authorized contact (gate)Named executive over the recordsSenior contact, authority unconfirmedNobody identifiedCEO

Two standards help an introducer recognize a strong answer. FHIR, the HL7 exchange standard, separates a result marked "corrected" to fix an error from one "amended" with new information, so a lab that records this distinction is telling you why each change happened. FHIR's Provenance resource records which person, software or device created or revised each version; a lab with audit trails of that kind scores well on the original-and-reason row even if it does not use FHIR.

Outside the U.S., Canada and the EU, add English share as a gate. Companies in the U.S., Canada and the EU qualify, as do companies in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia when at least 70% of the data is in English.

Three Illustrative laboratories, rated

All three are fictional.

Criterion450-person clinical reference lab120-person veterinary diagnostics lab75-person food testing lab, India
Company sizeStrongStrongStrong
Operating historyStrongStrongBorderline
RightsBorderlineStrongWeak
Original and reason keptStrongBorderlineBorderline
Hop linkageStrongStrongWeak
Interface log retentionStrongWeakWeak
Mapping change controlBorderlineBorderlineWeak
Authorized contactStrongStrongBorderline
Strong answers6 of 8, strong5 of 8, borderline1 of 8, weak; rights gate failed

The reference lab archives outbound HL7 messages for three years and links every hop by accession number. Rights are borderline because several hospital clients have contracts nobody has read for data-use terms, and mapping changes are dated but not ticketed.

The veterinary lab is strong on structure, but its interface engine purges message logs after 30 days, so the one hop that most often explains a cross-system error survives only for recent cases.

The food testing lab issues reports in English and Hindi, so the 70% English rule is in doubt, and its manufacturer clients own the results under contract. It has good quality habits; it does not have localizable errors it can license today.

Five questions that change a rating

Ask in this order, and listen for numbers and system names rather than "a few" or "our system".

  1. How many corrected reports a month, and how many involve a unit, range or mapping problem rather than a re-test? Moves the original-and-reason row.
  2. Is the original kept alongside each corrected report, with the reason recorded? Keeping both is required for U.S. clinical labs; the reason is what makes a case usable.
  3. Can you see the value at each system it passes through, including the interface engine, and for how long? Moves linkage and log retention.
  4. When a mapping or template changes, is that change dated and tied to a ticket? Decides whether cases before and after a fix can be separated.
  5. Who owns the laboratory, interface and client-facing systems, and who can authorize a licensing discussion? Moves both gates; the laboratory director and COO usually own the records, and the CEO authorizes the discussion.

Weak answers to two of questions 1 to 3 usually mean the lab has quality data but not localized errors in the sense a buyer would test. Where interface logs live is covered on the integration error records page; what to inventory before a system replacement is in lab result correction histories; non-clinical labs are covered on the testing laboratory industry page.

What the rating cannot settle

The rating records what the lab says. It cannot show how many cases pass a fixed acceptance check, how patient identifiers at each hop would be de-identified, whether client or interface vendor contracts permit use, or whether any buyer wants this task. Those are settled in SourceX's review with the company. The evidence gaps analysis shows how to word borderline rows, and the review packet list shows what the lab prepares later. For the broader introducer role, see the business introducer guide to operational data licensing; other record families are under data types.

Next step

Refer a company. No cap on rewards. Default reward on a company's first qualifying transaction: the greater of $50,000 plus 5% and 15% of Actual Supplier Payout, with no cap; further qualifying transactions first agreed within 12 months of the first Closing pay 15%. Eligibility and payment conditions apply, including the USD 100,000 Minimum Transaction, and a signed Schedule A or addendum can differ. A lead, meeting or signature alone does not trigger payment.

If the laboratory reaches the strong or borderline zone with all three gates passed, register as a partner, check it against who qualifies and read the terms before you introduce the CEO or COO.

  1. Step 1Share your linkSend your personal link to a company you know.
  2. Step 2Company appliesThe company applies itself at /apply.
  3. Step 3Company signs and is paidThe company signs, delivers its data and is paid by SourceX under its agreement.
  4. Step 4You get your rewardthe greater of $50,000 plus 5% and 15% of the actual supplier payout, with no cap. A reward becomes payable after SourceX has paid the referred company under its signed agreement and the payout conditions in the program terms are met, including finance approval and your tax and payment details.

Common questions

Does the laboratory have to be clinical?

No. Environmental, food, veterinary and industrial testing labs also pass values through several systems. Clinical labs are the clearest case because U.S. rules require corrected reports and retention of the original, which fixes part of the evidence in place.

Can I ask the lab to show me a corrected report so I can rate it properly?

No. Rate every criterion from what the quality manager or IT lead tells you about systems, counts and retention. Patient and client records stay with the lab until an agreement exists.

What if the lab scores well but its client contracts are unknown?

Mark rights as borderline and introduce with that open item named. Client and vendor terms are reviewed by SourceX with the company; the introducer only notes that they exist.

Sources

  1. ecfr.gov/current/title-42/chapter-IV/subchapter-G/par…
  2. law.cornell.edu/cfr/text/42/493.1105
  3. hl7.org/fhir/R4B/valueset-observation-status.html
  4. hl7.org/fhir/provenance.html
  5. refer.sourcex.si/terms

Free resources

Know a company with valuable proprietary data?

Become a referral partner, get your link and introduce the company’s CEO (in an owner-run company, usually the owner). Referral partners can join from most countries. We can't work with partners in countries or regions under U.S. sanctions or on U.S. restricted-party lists. The companies you introduce should be based in the U.S., Canada and the EU, or in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia with at least 70% of their data in English.

Refer a company →

I own a business

Explore licensing your company's data directly to SourceX for AI training and evaluation. Start a short assessment; no uploads needed.

Start an assessment